| 000 | 05032naa a22006377i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-055 | ||
| 003 | local | ||
| 005 | 20261005174905.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2019 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1128/cmr.00032-18 _2doi |
|
| 035 | _a(local)EuropePMC:PMC6589859 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aColleen S Kraft _eauthor. |
|
| 245 | 1 | 2 |
_aA Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides ( Clostridium ) difficile in Adults. / _cColleen S Kraft; J Scott Parrott; Nancy E Cornish [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bAmerican Society for Microbiology (ASM), _c2019. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aThe source lists 24 contributors; the first 12 names are recorded as access points. The complete source author list is retained in the catalogue manifest. | ||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aThe evidence base for the optimal laboratory diagnosis of Clostridioides ( Clostridium ) difficile in adults is currently unresolved due to the uncertain performance characteristics and various combinations of tests. This systematic review evaluates the diagnostic accuracy of laboratory testing algorithms that include nucleic acid amplification tests (NAATs) to detect the presence of C. difficile The systematic review and meta-analysis included eligible studies (those that had PICO [population, intervention, comparison, outcome] elements) that assessed the diagnostic accuracy of NAAT alone or following glutamate dehydrogenase (GDH) enzyme immunoassays (EIAs) or GDH EIAs plus C. difficile toxin EIAs (toxin). The diagnostic yield of NAAT for repeat testing after an initial negative result was also assessed. Two hundred thirty-eight studies met inclusion criteria. Seventy-two of these studies had sufficient data for meta-analysis. The strength of evidence ranged from high to insufficient. The uses of NAAT only, GDH-positive EIA followed by NAAT, and GDH-positive/toxin-negative EIA followed by NAAT are all recommended as American Society for Microbiology (ASM) best practices for the detection of the C. difficile toxin gene or organism. Meta-analysis of published evidence supports the use of testing algorithms that use NAAT alone or in combination with GDH or GDH plus toxin EIA to detect the presence of C. difficile in adults. There is insufficient evidence to recommend against repeat testing of the sample using NAAT after an initial negative result due to a lack of evidence of harm (i.e., financial, length of stay, or delay of treatment) as specified by the Laboratory Medicine Best Practices (LMBP) systematic review method in making such an assessment. Findings from this systematic review provide clarity to diagnostic testing strategies and highlight gaps, such as low numbers of GDH/toxin/PCR studies, in existing evidence on diagnostic performance, which can be used to guide future clinical research studies. | |
| 540 |
_aCreative Commons Attribution. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aMeta-analysis | |
| 650 | 4 | _aSystematic review | |
| 650 | 4 | _aLaboratory Diagnosis | |
| 650 | 4 | _aDiagnostic Accuracy | |
| 650 | 4 | _aC. Difficile Infection | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aclinical chemistry | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aJ Scott Parrott _eauthor. |
|
| 700 | 0 |
_aNancy E Cornish _eauthor. |
|
| 700 | 0 |
_aMatthew L Rubinstein _eauthor. |
|
| 700 | 0 |
_aAlice S Weissfeld _eauthor. |
|
| 700 | 0 |
_aPeggy McNult _eauthor. |
|
| 700 | 0 |
_aIrving Nachamkin _eauthor. |
|
| 700 | 0 |
_aRomney M Humphries _eauthor. |
|
| 700 | 0 |
_aThomas J Kirn _eauthor. |
|
| 700 | 0 |
_aJennifer Dien Bard _eauthor. |
|
| 700 | 0 |
_aJoseph D Lutgring _eauthor. |
|
| 700 | 0 |
_aJonathan C Gullett _eauthor. |
|
| 773 | 0 |
_tClinical microbiology reviews _gVol. 32, no. 3, (2019), pages/article e00032-18 _x0893-8512 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC6589859 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC6589859 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1197 _d1197 |
||